Goldman Sachs Group (GS)

Ceasefire hopes and lower crude prices powered the markets. Volatility index fell 2%, indicating improved investor confidence.

Shares of digital medical services platform Teladoc Health (NYSE:TDOC) jumped 10.9% in the afternoon session after Citron Research published a report highlighting the company's growth potential following Teladoc's impressive updates at a Goldman Sachs Healthcare conference. 

Top asset managers BlackRock and Goldman Sachs are closing several ESG-themed ETFs due to poor performance and lack of investor interest.

U.S. West Texas Intermediate (WTI) futures traded 6% lower at $69.41 per barrel at the time of writing, while Brent futures fell 5.6% to $71.25 per barrel.

Ortex data shows short interest in Enliven Therapeutics had hovered between 24% and 29% since October 2023.

Ives is of the view that a weakened Iran with no nuclear capacity would remove the biggest threat to the Middle East and Israel.

According to data from the Energy Information Administration, about 21 million barrels of oil passed through the Hormuz Strait each day in 2022.

For those interested in gaining exposure to the expected rapid growth in autonomous vehicles in the years ahead, Goldman Sachs recommends owning these three stocks...

Goldman Sachs warns Trump's spending plan won't slow debt, interest costs to top $1 trillion next year. Historic austerity drive may be necessary.

Analysts see a breakout above 24,920 as key to further upside, but caution remains amid global tensions.

The company is looking to raise ₹4,500 crore by selling a 11.6% stake. Analysts say the fundraise could ease debt, but biosimilar execution remains key.

With improving margins, consistent FII buying, and a robust demand outlook, the analyst is bullish on TD Power Systems.

NIO Inc. plans to expand into five more European markets by 2026, with a new distributor-based sales strategy. Goldman Sachs upgraded their rating to Neutral.

Analyst Tina Hou upgraded XPeng to ‘Buy’ from ‘Neutral’ with a price target of $24, up from $16.40.

CrowdStrike stock is up over 55% from February lows; analysts remain bullish, but institutional hedging suggests there may be some hedging through the summer

Analysts at Deutsche Bank expect the Incremental growth in higher-margin revenues and the breadth of its supply chain to help "deftly navigate" incremental tariffs and reinvest in growth.

The Wolfe analyst noted that the downgrade "is all about valuation" following the stock's nearly 50% gain this year.